Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Annexon Inc (ANNX)

Annexon Inc (ANNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Annexon Inc 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 USA

www.annexonbio.com Employees: 100 P: 650-822-5500 F: 650-636-9773

Sector:

Medical

Description:

Annexon Inc. is a clinical-stage biopharmaceutical company. It engages in developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company's product candidate includes ANX005 and ANX007, which are in clinical stage. Annexon Inc. is based in SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 726,172
Enterprise Value, $K 676,672
Shares Outstanding, K 119,633
Float, K 105,433
% Float 88.13%
Short Interest, K 12,204
Short Float 10.20%
Days to Cover 4.34
Short Volume Ratio 0.36
% of Insider Shareholders 11.87%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -138,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -54,920 K
EBIT, $ -218,640 K
EBITDA, $ -216,490 K

Growth:

1-Year Return 47.69%
3-Year Return -12.16%
5-Year Return -77.54%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/10/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -1.41
EPS Growth vs. Prev Qtr -8.82%
EPS Growth vs. Prev Year -48.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANNX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.28%
Return-on-Assets % -72.21%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.19
Book Value/Share 1.47
Interest Coverage -2.99
60-Month Beta 1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar